Citation APA
Yang, H., Bouma, B. U. N. B., Dimopoulos, K., Khairy, P., Ladouceur, M., Niwa, K., Greutmann, M., Schwerzmann, M., Egbe, A. C., Scognamiglio, G., Budts, W., Veldtman, G. G., Opotowsky, A., Broberg, C., Gumbiene, L., Meijboom, F., Rutz, T., Post, M. M., Moe, T., Lipczyńska, M., Tsai, S., Chakrabarti, S., Tobler, D., Davidson, W., Morissens, L., Van Dijk, A., Buber, J., Bouchardy, J., Skoglund, K., Christersson, C., Kronvall, T., Konings, T. T., Alonso-Gonzalez, R., Mizuno, A., Webb, G., Laukyte, M., Sieswerda, G. T. G., Shafer, K., Aboulhosn, J., & Mulder, B. B. (2019). Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study. International journal of cardiology. doi:10.1016/j.ijcard.2019.06.014
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/291308